Improved attention linked to sustained phenylalanine reduction in adults with early‐treated phenylketonuria-Reference-Cited by-同舟云学术

Improved attention linked to sustained phenylalanine reduction in adults with early‐treated phenylketonuria

Published:2021-11-26 Issue: Volume: Page:
ISSN:1552-4825
Container-title:American Journal of Medical Genetics Part A
language:en
Short-container-title:Am J Med Genet

Author:

Bilder Deborah A.¹^ORCID,Arnold Georgianne L.²,Dimmock David³,Grant Mitzie L.⁴,Janzen Darren⁵,Longo Nicola⁶,Nguyen‐Driver Mina⁵,Jurecki Elaina⁷,Merilainen Markus⁷,Amato Gianni⁷⁸,Waisbren Susan⁹

Affiliation:

1. Department of Psychiatry, Division of Child & Adolescent Psychiatry University of Utah Huntsman Mental Health Institute Salt Lake City Utah USA

2. Department of Genetics UPMC Children's Hospital of Pittsburgh Pittsburgh Pennsylvania USA

3. Rady Children's Institute for Genomic Medicine San Diego California USA

4. Department of Academic Psychiatry Drexel University College of Medicine and St. Christopher's Hospital for Children Philadelphia Pennsylvania USA

5. Department of Pediatrics, Division of Pediatric Psychology Oregon Health & Science University Portland Oregon USA

6. Department of Pediatrics, Division of Medical Genetics University of Utah School of Medicine Salt Lake City Utah USA

7. BioMarin Pharmaceutical Inc. Novato California USA

8. Biostats LLC San Francisco California USA

9. Department of Medicine, Division of Genetics and Genomics Boston Children's Hospital and Harvard Medical School Boston Massachusetts USA

Funder

BioMarin Pharmaceutical

Publisher

Wiley

Subject

Genetics(clinical),Genetics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajmg.a.62574

Reference36 articles.

1. Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder

2. Neuropsychological speed tests and blood phenylalanine levels in patients with phenylketonuria: A meta-analysis

3. Diagnostic and Statistical Manual of Mental Disorders

4. Are Neuropsychological Impairments in Children with Early-Treated Phenylketonuria (PKU) Related to White Matter Abnormalities or Elevated Phenylalanine Levels?

5. Psychiatric and Cognitive Aspects of Phenylketonuria: The Limitations of Diet and Promise of New Treatments

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurocognitive assessment platform for clinical trials in PKU: White paper developed by the NPKUA neurocognitive workgroup;Molecular Genetics and Metabolism;2024-09

2. Adherence to PKU guidelines among patients with phenylketonuria: A cross-sectional national multicenter survey-based study in Argentina, Brazil, and Mexico;Molecular Genetics and Metabolism Reports;2024-03

3. Best practice recommendations for the management of anxiety during the pegvaliase journey;Molecular Genetics and Metabolism;2024-01

4. Expert Consensus on the Long-Term Effectiveness of Medical Nutrition Therapy and Its Impact on the Outcomes of Adults with Phenylketonuria;Nutrients;2023-09-11

5. Neuropsychiatric Function Improvement in Pediatric Patients with Phenylketonuria;The Journal of Pediatrics;2023-09